Cited In for PMID: 27727447

Year	Number of Results
2016	1
2017	2
2018	5
2019	3
2020	8
2021	2
2022	3
2023	5
2024	1

1

A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma.

Pal SK, Drabkin HA, Reeves JA, Hainsworth JD, Hazel SE, Paggiarino DA, Wojciak J, Woodnutt G, Bhatt RS. Pal SK, et al. Cancer. 2017 Feb 15;123(4):576-582. doi: 10.1002/cncr.30393. Epub 2016 Oct 11. Cancer. 2017. PMID: 27727447 Free article. Clinical Trial.

2

Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.

Nagahashi M, Miyoshi Y. Nagahashi M, et al. Int J Mol Sci. 2024 Mar 15;25(6):3354. doi: 10.3390/ijms25063354. Int J Mol Sci. 2024. PMID: 38542328 Free PMC article. Review.

3

The role of sphingosine-1-phosphate in autophagy and related disorders.

Xiao S, Peng K, Li C, Long Y, Yu Q. Xiao S, et al. Cell Death Discov. 2023 Oct 18;9(1):380. doi: 10.1038/s41420-023-01681-x. Cell Death Discov. 2023. PMID: 37852968 Free PMC article. Review.

4

Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer.

Mebarek S, Skafi N, Brizuela L. Mebarek S, et al. Cancers (Basel). 2023 May 12;15(10):2732. doi: 10.3390/cancers15102732. Cancers (Basel). 2023. PMID: 37345069 Free PMC article. Review.

5

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies.

Zhang Y, Popel AS, Bazzazi H. Zhang Y, et al. ACS Pharmacol Transl Sci. 2023 Apr 18;6(5):710-726. doi: 10.1021/acsptsci.3c00008. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200806 Free PMC article.

6

Lipids as Targets for Renal Cell Carcinoma Therapy.

Stepanovska Tanturovska B, Manaila R, Fabbro D, Huwiler A. Stepanovska Tanturovska B, et al. Int J Mol Sci. 2023 Feb 7;24(4):3272. doi: 10.3390/ijms24043272. Int J Mol Sci. 2023. PMID: 36834678 Free PMC article. Review.

7

Targeting lipid metabolism in metastatic prostate cancer.

Scheinberg T, Mak B, Butler L, Selth L, Horvath LG. Scheinberg T, et al. Ther Adv Med Oncol. 2023 Jan 30;15:17588359231152839. doi: 10.1177/17588359231152839. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36743527 Free PMC article. Review.

8

Molecular signature of renal cell carcinoma by means of a multiplatform metabolomics analysis.

Kordalewska M, Wawrzyniak R, Jacyna J, Godzień J, López Gonzálves Á, Raczak-Gutknecht J, Markuszewski M, Gutknecht P, Matuszewski M, Siebert J, Barbas C, Markuszewski MJ. Kordalewska M, et al. Biochem Biophys Rep. 2022 Aug 4;31:101318. doi: 10.1016/j.bbrep.2022.101318. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 35967759 Free PMC article.

9

Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment.

Janneh AH, Ogretmen B. Janneh AH, et al. Cancers (Basel). 2022 Apr 27;14(9):2183. doi: 10.3390/cancers14092183. Cancers (Basel). 2022. PMID: 35565311 Free PMC article. Review.

10

Keep a Little Fire Burning-The Delicate Balance of Targeting Sphingosine-1-Phosphate in Cancer Immunity.

Olesch C, Brüne B, Weigert A. Olesch C, et al. Int J Mol Sci. 2022 Jan 24;23(3):1289. doi: 10.3390/ijms23031289. Int J Mol Sci. 2022. PMID: 35163211 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year